Adjuvant therapy of resected non-small-cell lung cancer

Steven M. Keller

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.

Original languageEnglish (US)
Pages (from-to)149-155
Number of pages7
JournalCurrent Opinion in Oncology
Volume12
Issue number2
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Meta-Analysis
Radiotherapy
Recurrence
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Adjuvant therapy of resected non-small-cell lung cancer. / Keller, Steven M.

In: Current Opinion in Oncology, Vol. 12, No. 2, 2000, p. 149-155.

Research output: Contribution to journalArticle

Keller, Steven M. / Adjuvant therapy of resected non-small-cell lung cancer. In: Current Opinion in Oncology. 2000 ; Vol. 12, No. 2. pp. 149-155.
@article{7f9d4d9ac1994f57935cd94034f3cc13,
title = "Adjuvant therapy of resected non-small-cell lung cancer",
abstract = "The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.",
author = "Keller, {Steven M.}",
year = "2000",
doi = "10.1097/00001622-200003000-00009",
language = "English (US)",
volume = "12",
pages = "149--155",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Adjuvant therapy of resected non-small-cell lung cancer

AU - Keller, Steven M.

PY - 2000

Y1 - 2000

N2 - The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.

AB - The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.

UR - http://www.scopus.com/inward/record.url?scp=0034509439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034509439&partnerID=8YFLogxK

U2 - 10.1097/00001622-200003000-00009

DO - 10.1097/00001622-200003000-00009

M3 - Article

C2 - 10750727

AN - SCOPUS:0034509439

VL - 12

SP - 149

EP - 155

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 2

ER -